Research




Appriss Health Unveils 2020 Behavioral Health Report

Helping government, hospitals, health plans, and pharmacies combat the U.S. mental health crisis and substance use epidemic Appriss Health, a technology company delivering point-of-care and data-sharing solutions addressing public health outcomes, announced the release of…






Immunai Raises $60M to Reprogram Immunity

The funding will fuel the growth of Immunai’s proprietary AI-first single-cell drug discovery platform Immunai, a New York and Tel Aviv based biotech company, announced today $60M in funding, increasing the company’s total funding-to-date to…